CorTec is part of an international clinical study that will enable severely paralyzed people to communicate again – with the help of an implantable brain-computer interface. It is a vision that has been at the core of CorTec’s DNA since its inception more than 10 years ago by now: Brain-Computer Interfaces (BCI) that enable severely […]
Speak your mind! – Pilot clinical study with severely paralyzed patients Read More »
The proprietary CorTec neuromodulation system “Brain Interchange” was developed for the discovery of novel neurotherapies. With funding by the US-American National Institutes of Health (NIH), and in collaboration with one of the world leaders in the field, Professor Dr. Jeff Ojemann and his team from the University of Washington School of Medicine in Seattle,
With the support of the Netherlands Organisation for Scientific Research, a new research network was established in 2021 that aims to develop new neurotechnological therapies for blindness, deafness, paralysis, and epilepsy. By combining recent knowledge about the brain with new possibilities within neurotechnology, the network’s approach is to establish high-bandwidth, wireless interfaces to the human
INTENSE: Dutch neurotechnology network on brain-machine interfaces Read More »
For the second time the Bernstein-CorTec Award was given in recognition of outstanding achievements at the University of Freiburg. The cooperation between CorTec and the Bernstein-Center Freiburg [BCF] makes it possible to award a prize money of 1000 € for master and doctoral theses in the interdisciplinary field of Neurotechnology and Computational Neuroscience. This year,
Bernstein-CorTec Award & the Bernstein Special Seminar Read More »
Most users of CorTec’s implantable electrodes use electrical energy to power their neurostimulation device. Our long-standing collaboration partner Synergia Medical is exploring an alternative option: Light! A special promise of optoelectronic solutions is based on the fact that they can use light conductors instead of metallic cables for energy transmission. Metallic cabling poses a risk
Seeing the light for treatment-resistant epilepsy Read More »
As CorTec grows and pursues novel therapeutic applications together with partners, the attendant regulatory, quality assurance, and clinical complexities facing the business increase. We are therefore pleased to announce that Claus Freyinger has joined CorTec in the position of Chief Regulatory & Clinical Officer as of September 1, 2021, relocating from San Francisco, CA to
New Member of the Management Team at CorTec Read More »
For the second time we will be able to present the Bernstein-CorTec Award this year. The cooperation between CorTec and the Bernstein-Center Freiburg makes it possible to award a prize money of 1000 € for master and doctoral theses in the interdisciplinary field of Neurotechnology and Computational Neuroscience. The award is given in recognition of
Call for Nominations – the Bernstein-CorTec Award 2021 Read More »
Research and development are the focus of our work. With a highly skilled team we are working closely together with our partners to promote and deploy the technology developed by us in funded projects. Today we would like to introduce the Moore4Medical* project to you. It is the overarching objective of Moore4Medical to accelerate innovation
CorTec introduces Moore4Medical Read More »
CorTec is offering a wide spectrum of services accompanying you all the way through the development of innovative technologies leading to an approved medical device in the end. One step on that way is to design application specific mouldings to protect the sensitive parts of the implant, such as its electronics with our encapsulation technology.
Fast Design Iterations for Precise Silicone Moulds for Active Implants Read More »
Our pictures of the year don’t come from just anyone. Each one is the work of one of our employees who have documented a variety of events in our daily work throughout the year. As 2020 faced us all with unexpected and new challenges, our photo gallery not only includes our technology and products but
Pictures of the year 2020 Read More »
FEATURE
Recording channels
Sampling rate
Sampling dynamic range
High pass filter cut-off
Low pass filter cut-off
Amplifier band pass gain
Band pass roll-off
Reference
Stimulation
Stimulation channels
Current
Current source
Pulse width
Power supply
Wireless data transmission
Closed Loop latency
VALUE
32
1 kHz
16 bit (74 nV smallest increment)
ca. 2 Hz
325 Hz
Adjustable: 100-750
20 dB/dec
Any (subset) of the recording channels selectable by software or one dedicated hard-wired additional contact
Current-controlled, biphasic, rectangular, asymmetric stimulus pulses (cathodic amplitude with pulse width followed by an anodic counter pulse of 1/4x amplitude and 4x pulse width)
32
Max. -6 mA / +1.5 mA (24 µA increments) within
compliance voltage range of -11 V to +5 V
Can be directed to any of the 32 electrode contacts
Negative phase: 10 µs – 2,500 µs
Wireless inductive, 120-140 kHz
Bi-directional, radio frequency in 2400-2483.5 MHz band ≤ 40 ms
We’re happy to help you realize your next project. Whether it is a complete implantable system design, an electrode or another component.
Please fill out the form below and our sales team will be in contact with you shortly.